OPDIVO QVANTIG

E.R. Squibb & Sons, L.L.C.🇺🇸 United States

FDA Page

Effective Date: May 12, 2026
Approval ID: 7f8c38fa-42f4-4387-9e8c-7a1c66855d8b
Products: 2 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OPDIVO QVANTIG safely and effectively. See full prescribing information for OPDIVO QVANTIG.OPDIVO QVANTIG™ (nivolumab and hyaluronidase-nvhy) injection, for subcutaneous use.Initial U.S. Approval: 2024

Quick Stats

Total Products2

Labelers1

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.